Laddar...
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
The astonishing clinical success of CD19 chimeric antigen receptor (CAR) T-cell therapy has led to the approval of two second generation chimeric antigen receptors (CARs) for acute lymphoblastic leukemia (ALL) andnon-Hodgkin lymphoma (NHL). The focus of the field is now on emulating these successes...
Sparad:
| I publikationen: | J Vis Exp |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
MyJove Corporation
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6235544/ https://ncbi.nlm.nih.gov/pubmed/30394400 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3791/58492 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|